Has Gerard Henry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $489,496 in general payments to Gerard Henry, MD across 1,127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gerard Henry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gerard Henry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gerard Henry, MD

Urology · Bossier City, LANPI 1508862905

Payments from drug & device makers

$489,496in general payments, 2019–2025

Across 1,127 payments — averaging $434.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$243K
Bluewind Medical$72K
Coloplast$65K
Pfizer$64K
EDAP Technomed Inc$23K
Axonics, Inc.$12K
plus $11K from 48 others

$50,034in research payments, 2019–2025

Across 7 payments — averaging $7147.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Coloplast$50K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	185	$243,185
Bluewind Medical	35	$71,526
Coloplast	271	$64,970
Pfizer	62	$63,952
EDAP Technomed Inc	29	$23,096
Axonics, Inc.	41	$11,761
Innovation Technologies Inc	7	$2,066
Endo Pharmaceuticals Inc.	98	$1,217
Medtronic(2 entities)	89	$1,053
Astellas Pharma US Inc	52	$966
AbbVie(2 entities)	49	$955
Johnson & Johnson(2 entities)	54	$759
Endo USA, Inc.	15	$365
Teleflex LLC	8	$350
Sun Pharmaceutical Industries Inc.	15	$347
Bayer	16	$339
Sumitomo Pharma America, Inc.	9	$304
Antares Pharma, Inc.	16	$262
Progenics Pharmaceuticals, Inc.	7	$241
Profound Medical Corp.	2	$221
Urogen Pharma, Inc.	1	$156
Tolmar, Inc.	6	$105
Urovant Sciences Inc	4	$98
Immunitybio, Inc.	1	$97
Ferring Pharmaceuticals Inc.	4	$84
Blue Earth Diagnostics	4	$72
Rochester Medical Corporation	3	$70
180 Medical, Inc.	3	$65
Valencia Technologies Corporation	3	$64
Neotract Inc.	3	$58
Dendreon Pharmaceuticals LLC	2	$57
Telix Pharmaceuticals	2	$47
Bioprotect Medical, Inc.	2	$44
Myriad Genetic Laboratories, Inc.	2	$42
Tolmar Pharmaceuticals, Inc.	2	$41
Photocure Inc	2	$41
Cook Medical LLC	1	$37
AstraZeneca	2	$37
Travere Therapeutics, Inc.	3	$35
Accord Healthcare, Inc.	2	$34
Procept Biorobotics Corporation	1	$32
Amgen	2	$27
Olympus America Inc.	1	$23
Myovant Sciences Inc.	1	$23
Pacira Pharmaceuticals Incorporated	1	$22
Laborie Medical Technologies Corp.	1	$21
C. R. Bard, Inc. & Subsidiaries	1	$20
Smith+Nephew	1	$19
Clarus Therapeutics Inc.	1	$18
Kowa Pharmaceuticals America, Inc.	1	$17
Convatec Inc.	1	$17
Civco Medical Instruments	1	$16
Metuchen Pharmaceuticals	1	$13
Dentsply IH Inc.	1	$12

How this compares

$489,496 in reported general payments places this provider in the 95th percentile of 199 urology providers in Louisiana.

See all urology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$672,985

Medicare patients

516

Services billed

244,645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Bossier City

William BundrickBossier City$8K
Ralph HendersonShreveport$4M
Kevin ClineShreveport$1.3M
Nathan FischmanNew Orleans$1.3M
Ashley BakerShreveport$705K
Colin GoudelockeNew Orleans$615K
Stephen BardotNew Orleans$572K
Jared MossShreveport$365K
Richard VanlangendonckNew Orleans$289K
James NobleShreveport$273K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →